Republicans and Democrats find a unifying target: Pharmacy benefit managers
Republicans and Democrats are finding common ground in their criticism of pharmacy benefit managers (PBMs), which they argue are driving up healthcare costs. Legislative efforts are increasing to restrict companies from owning both PBMs and retail pharmacies simultaneously.
Why it matters
This bipartisan alignment on healthcare regulation highlights a rare point of political consensus in a polarized environment, potentially leading to significant industry reform.
Amye Joseph says America's political polarization has made it an "interesting time" in her Tennessee household.
She and her husband, Charlie, have been married for 35 years. She's a Republican. He's a Democrat. But their shared disenchantment with profit-driven healthcare has provided a unifying target: pharmacy benefit managers, known as PBMs.
This story was produced in partnership with KFF Health News .
The Josephs' frustration is focused on CVS Health. The conglomerate, which reported $400 billion in revenue last year, includes a major health insurer (Aetna), one of the country's dominant PBMs (CVS Caremark), and America's largest retail pharmacy chain (CVS Pharmacy).
"We hate CVS. I'm going to be straight-up," Amye Joseph said.
She laments the lack of face-to-face interaction with pharmacists, prices that seem to rise without explanation, and pressure from the couple's CVS Caremark drug plan to use CVS stores instead of their local pharmacy.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in